ArticleTherapeutic advances in gastroenterology2022

Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy.

María José García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.